Literature DB >> 21796641

MicroRNA expression is differentially altered by xenobiotic drugs in different human cell lines.

Alice C Rodrigues1, Xin Li, Laura Radecki, Yu-Zhuo Pan, Jerrold C Winter, Min Huang, Ai-Ming Yu.   

Abstract

Several noncoding microRNAs (miR or miRNA) have been shown to regulate the expression of drug-metabolizing enzymes and transporters. Xenobiotic drug-induced changes in enzyme and transporter expression may be associated with the alteration of miRNA expression. Therefore, this study investigated the impact of 19 xenobiotic drugs (e.g. dexamethasone, vinblastine, bilobalide and cocaine) on the expression of ten miRNAs (miR-18a, -27a, -27b, -124a, -148a, -324-3p, -328, -451, -519c and -1291) in MCF-7, Caco-2, SH-SY5Y and BE(2)-M17 cell systems. The data revealed that miRNAs were differentially expressed in human cell lines and the change in miRNA expression was dependent on the drug, as well as the type of cells investigated. Notably, treatment with bilobalide led to a 10-fold increase of miR-27a and a 2-fold decrease of miR-148a in Caco-2 cells, but no change of miR-27a and a 2-fold increase of miR-148a in MCF-7 cells. Neuronal miR-124a was generally down-regulated by psychoactive drugs (e.g. cocaine, methadone and fluoxetine) in BE(2)-M17 and SH-SY5Y cells. Dexamethasone and vinblastine, inducers of drug-metabolizing enzymes and transporters, suppressed the expression of miR-27b, -148a and -451 that down-regulate the enzymes and transporters. These findings should provide increased understanding of the altered gene expression underlying drug disposition, multidrug resistance, drug-drug interactions and neuroplasticity.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21796641      PMCID: PMC3158292          DOI: 10.1002/bdd.764

Source DB:  PubMed          Journal:  Biopharm Drug Dispos        ISSN: 0142-2782            Impact factor:   1.627


  56 in total

Review 1.  Epigenetic and microRNA-dependent control of cytochrome P450 expression: a gap between DNA and protein.

Authors:  Alvin Gomez; Magnus Ingelman-Sundberg
Journal:  Pharmacogenomics       Date:  2009-07       Impact factor: 2.533

2.  MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells.

Authors:  Yu-Zhuo Pan; Marilyn E Morris; Ai-Ming Yu
Journal:  Mol Pharmacol       Date:  2009-03-06       Impact factor: 4.436

3.  Dexamethasone down-regulates ABCG2 expression levels in breast cancer cells.

Authors:  Mylène Honorat; Aurélia Mesnier; Attilio Di Pietro; Valérie Lin; Pascale Cohen; Charles Dumontet; Léa Payen
Journal:  Biochem Biophys Res Commun       Date:  2008-08-08       Impact factor: 3.575

4.  Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells.

Authors:  Hua Zhu; Hao Wu; Xiuping Liu; Brad R Evans; Daniel J Medina; Chang-Gong Liu; Jin-Ming Yang
Journal:  Biochem Pharmacol       Date:  2008-06-24       Impact factor: 5.858

5.  MicroRNA 18 and 124a down-regulate the glucocorticoid receptor: implications for glucocorticoid responsiveness in the brain.

Authors:  Erno Vreugdenhil; Carla S L Verissimo; Rob Mariman; Jessica T Kamphorst; Joana S Barbosa; Thijs Zweers; Danielle L Champagne; Theo Schouten; Onno C Meijer; E Ron de Kloet; Carlos P Fitzsimons
Journal:  Endocrinology       Date:  2009-01-08       Impact factor: 4.736

6.  Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells.

Authors:  Yiwei Li; Timothy G VandenBoom; Dejuan Kong; Zhiwei Wang; Shadan Ali; Philip A Philip; Fazlul H Sarkar
Journal:  Cancer Res       Date:  2009-08-04       Impact factor: 12.701

7.  Bioactive terpenoids and flavonoids from Ginkgo biloba extract induce the expression of hepatic drug-metabolizing enzymes through pregnane X receptor, constitutive androstane receptor, and aryl hydrocarbon receptor-mediated pathways.

Authors:  Linhao Li; Joseph D Stanton; Antonia H Tolson; Yuan Luo; Hongbing Wang
Journal:  Pharm Res       Date:  2008-11-26       Impact factor: 4.200

8.  MicroRNA regulates human vitamin D receptor.

Authors:  Takuya Mohri; Miki Nakajima; Shingo Takagi; Sayaka Komagata; Tsuyoshi Yokoi
Journal:  Int J Cancer       Date:  2009-09-15       Impact factor: 7.396

9.  MicroRNAs regulate CYP3A4 expression via direct and indirect targeting.

Authors:  Yu-Zhuo Pan; Wenqing Gao; Ai-Ming Yu
Journal:  Drug Metab Dispos       Date:  2009-07-06       Impact factor: 3.922

10.  MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells.

Authors:  Wan-Hsin Liu; Shiou-Hwei Yeh; Cho-Chun Lu; Sung-Liang Yu; Hsuan-Yu Chen; Chien-Yu Lin; Ding-Shinn Chen; Pei-Jer Chen
Journal:  Gastroenterology       Date:  2008-11-01       Impact factor: 22.682

View more
  25 in total

Review 1.  MicroRNAs in opioid pharmacology.

Authors:  Cheol Kyu Hwang; Yadav Wagley; Ping-Yee Law; Li-Na Wei; Horace H Loh
Journal:  J Neuroimmune Pharmacol       Date:  2011-11-09       Impact factor: 4.147

2.  MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies.

Authors:  Ronit Vogt Sionov
Journal:  ISRN Hematol       Date:  2013-01-29

Review 3.  The effects of microRNA on the absorption, distribution, metabolism and excretion of drugs.

Authors:  Y He; J R Chevillet; G Liu; T K Kim; K Wang
Journal:  Br J Pharmacol       Date:  2014-12-01       Impact factor: 8.739

4.  Integrated microRNA-mRNA analysis of coronary artery disease.

Authors:  Fei Chen; Xin Zhao; Juan Peng; LinPing Bo; Bing Fan; Duan Ma
Journal:  Mol Biol Rep       Date:  2014-06-10       Impact factor: 2.316

5.  Transcriptome association analysis identifies miR-375 as a major determinant of variable acetaminophen glucuronidation by human liver.

Authors:  Ioannis Papageorgiou; Marina Freytsis; Michael H Court
Journal:  Biochem Pharmacol       Date:  2016-08-13       Impact factor: 5.858

6.  Atorvastatin attenuation of ABCB1 expression is mediated by microRNA miR-491-3p in Caco-2 cells.

Authors:  Alice C Rodrigues; Elida Adalgisa Neri; Sidney Veríssimo-Filho; Nancy Amaral Rebouças; Rosario D C Hirata; Ai-Ming Yu
Journal:  Eur J Pharm Sci       Date:  2016-08-26       Impact factor: 4.384

7.  Small nucleolar RNA-derived microRNA hsa-miR-1291 modulates cellular drug disposition through direct targeting of ABC transporter ABCC1.

Authors:  Yu-Zhuo Pan; Amy Zhou; Zihua Hu; Ai-Ming Yu
Journal:  Drug Metab Dispos       Date:  2013-05-16       Impact factor: 3.922

8.  Noncoding microRNAs: small RNAs play a big role in regulation of ADME?

Authors:  Ai-Ming Yu; Yu-Zhuo Pan
Journal:  Acta Pharm Sin B       Date:  2012-03-31       Impact factor: 11.413

Review 9.  Emerging Roles for MicroRNAs in Perioperative Medicine.

Authors:  Viola Neudecker; Kelley S Brodsky; Simone Kreth; Adit A Ginde; Holger K Eltzschig
Journal:  Anesthesiology       Date:  2016-02       Impact factor: 7.892

10.  The Promises of Quantitative Proteomics in Precision Medicine.

Authors:  Bhagwat Prasad; Marc Vrana; Aanchal Mehrotra; Katherine Johnson; Deepak Kumar Bhatt
Journal:  J Pharm Sci       Date:  2016-12-08       Impact factor: 3.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.